Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Stem Cell Research

Free Subscription Articles published in Leuk Res Retrieve available abstracts of 39 articles: HTML format Text format

Single Articles

July 2018
1. OGATA K, Sei K, Saft L, Kawahara N, et al
   Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
   Leuk Res. 2018;71:75-81.
   PubMed     Text format     Abstract available
   
   
   June 2018
2. LIU C, Wei H, Yao X, Liu B, et al
   Retraction notice to "Arsenic Trioxide Inhibits Proliferation and Induced apoptosis of Leukemia Stem Cells with Drug Resistance " [LR 69 (2018) 66-71].
   Leuk Res. 2018;69:103.
   PubMed     Text format    
   
   
   May 2018
3. IOVINO L, Mazziotta F, Carulli G, Guerrini F, et al
   High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation.
   Leuk Res. 2018;70:20-24.
   PubMed     Text format     Abstract available
   
   
   April 2018
4. TANG L, Wang N, Xing C, Zhuang Q, et al
   Effect of absolute monocyte count post-transplant on the outcome of patients with acute myeloid leukemia undergoing myeloablative allogeneic hematopoietic stem cell transplant with busulfan and cyclophosphamide conditioning.
   Leuk Res. 2018;69:60-65.
   PubMed     Text format     Abstract available
   
   
   
5. PARK H, Lee YJ, Shin SJ, Lee J, et al
   Which donor is better when a matched donor is not available domestically? Comparison of outcomes of allogeneic stem cell transplantation with haploidentical and international donors in a homogenous ethnic population.
   Leuk Res. 2018;69:31-38.
   PubMed     Text format     Abstract available
   
   
   March 2018
6. LIU C, Wei H, Yao X, Liu B, et al
   Arsenic trioxide inhibits proliferation and induced apoptosis of leukemia stem cells with drug resistance.
   Leuk Res. 2018;69:66-71.
   PubMed     Text format     Abstract available
   
   
   January 2018
7. CUI P, Zhang Y, Cui M, Li Z, et al
   Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.
   Leuk Res. 2018;65:49-54.
   PubMed     Text format     Abstract available
   
   
   November 2017
8. LEON-RODRIGUEZ E, Rivera-Franco MM, Gomez-Martin D, Romo-Tena J, et al
   Differential T cell subsets and cytokine profile between steady-state and G-CSF-primed bone marrow and its association with graft-versus-host disease.
   Leuk Res. 2017;63:47-52.
   PubMed     Text format     Abstract available
   
   
   October 2017
9. OZDOGAN H, Gur Dedeoglu B, Oztemur Islakoglu Y, Aydos A, et al
   DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
   Leuk Res. 2017;63:62-71.
   PubMed     Text format     Abstract available
   
   
   
10. CANDONI A, De Marchi F, Zannier ME, Lazzarotto D, et al
    High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
    Leuk Res. 2017;63:22-27.
    PubMed     Text format     Abstract available
    
    
    September 2017
11. AZUMA K, Umezu T, Imanishi S, Asano M, et al
    Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.
    Leuk Res. 2017;62:23-28.
    PubMed     Text format     Abstract available
    
    
    
12. OU R, Huang J, Shen H, Liu Z, et al
    Transcriptome analysis of CD34+ cells from myelodysplastic syndrome patients.
    Leuk Res. 2017;62:40-50.
    PubMed     Text format     Abstract available
    
    
    July 2017
13. AGGOUNE D, Sorel N, Bonnet ML, Goujon JM, et al
    Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs).
    Leuk Res. 2017;60:94-102.
    PubMed     Text format     Abstract available
    
    
    
14. YANG H, Zheng Y, Zhang Y, Cao Z, et al
    Mesenchymal stem cells derived from multiple myeloma patients protect against chemotherapy through autophagy-dependent activation of NF-kappaB signaling.
    Leuk Res. 2017;60:82-88.
    PubMed     Text format     Abstract available
    
    
    June 2017
15. CHEN H, Liu KY, Xu LP, Chen YH, et al
    Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era.
    Leuk Res. 2017;59:136-141.
    PubMed     Text format     Abstract available
    
    
    May 2017
16. GU B, Wu X, Chen G, Ma X, et al
    Haploidentical allogeneic hematopoietic stem cell transplantation compared to matched unrelated transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Leuk Res. 2017;59:41-46.
    PubMed     Text format     Abstract available
    
    
    
17. TAN J, Wang Y, Yu SJ, Ma YY, et al
    Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia.
    Leuk Res. 2017;59:1-7.
    PubMed     Text format     Abstract available
    
    
    April 2017
18. MEDINGER M, Zeiter D, Heim D, Halter J, et al
    Hypothyroidism following allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
    Leuk Res. 2017;58:43-47.
    PubMed     Text format     Abstract available
    
    
    March 2017
19. GONZALEZ-VICENT M, Molina B, Deltoro N, Sevilla J, et al
    Donor age matters in T-cell depleted haploidentical hematopoietic stem cell transplantation in pediatric patients: Faster immune reconstitution using younger donors.
    Leuk Res. 2017;57:60-64.
    PubMed     Text format     Abstract available
    
    
    February 2017
20. GAO L, Liu J, Zhang Y, Chen X, et al
    Low incidence of acute graft-versus-host disease with short-term tacrolimus in haploidentical hematopoietic stem cell transplantation.
    Leuk Res. 2017;57:27-36.
    PubMed     Text format     Abstract available
    
    
    
21. ZHAO P, Chen Y, Yue Z, Yuan Y, et al
    Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway.
    Leuk Res. 2017;57:20-26.
    PubMed     Text format     Abstract available
    
    
    
22. ZEIDAN AM, Battiwalla M, Berlyne D, Winkler T, et al
    Aplastic Anemia and MDS International Foundation (AAMDSIF): Bone marrow failure disease scientific symposium 2016.
    Leuk Res. 2017;53:8-12.
    PubMed     Text format     Abstract available
    
    
    January 2017
23. YAO J, Zhang G, Liang C, Li G, et al
    Combination of cytogenetic classification and MRD status correlates with outcome of autologous versus allogeneic stem cell transplantation in adults with primary acute myeloid leukemia in first remission.
    Leuk Res. 2017;55:97-104.
    PubMed     Text format     Abstract available
    
    
    
24. DING L, Zhu H, Yang Y, Yan HM, et al
    The absolute number of regulatory T cells in unmanipulated peripheral blood grafts predicts the occurrence of acute graft-versus-host disease post haplo-identical hematopoietic stem cell transplantation.
    Leuk Res. 2017;56:13-20.
    PubMed     Text format     Abstract available
    
    
    
25. DROKOV MY, Davydova JO, Kuzmina LA, Galtseva IV, et al
    Level of Granzyme B-positive T-regulatory cells is a strong predictor biomarker of acute Graft-versus-host disease after day +30 after allo-HSCT.
    Leuk Res. 2017;54:25-29.
    PubMed     Text format     Abstract available
    
    
    
26. WANG L, Raffoux E, Thomas X, Yakoub-Agha I, et al
    Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA.
    Leuk Res. 2017;54:12-16.
    PubMed     Text format     Abstract available
    
    
    December 2016
27. LAZZAROTTO D, Candoni A, Fili C, Forghieri F, et al
    Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.
    Leuk Res. 2016;53:74-81.
    PubMed     Text format     Abstract available
    
    
    
28. HEINI AD, Berger MD, Seipel K, Taleghani BM, et al
    Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years.
    Leuk Res. 2016;53:28-34.
    PubMed     Text format     Abstract available
    
    
    November 2016
29. CHAVEZ-GONZALEZ A, Centeno-Llanos S, Moreno-Lorenzana D, Sandoval-Esquivel MA, et al
    Casiopeina III-Ea, a copper-containing small molecule, inhibits the in vitro growth of primitive hematopoietic cells from chronic myeloid leukemia.
    Leuk Res. 2016;52:8-19.
    PubMed     Text format     Abstract available
    
    
    July 2016
30. GHOBADI A, Choi J, Fiala MA, Fletcher T, et al
    Phase I study of azacitidine following donor lymphocyte infusion for relapsed acute myeloid leukemia post allogeneic stem cell transplantation.
    Leuk Res. 2016;49:1-6.
    PubMed     Text format     Abstract available
    
    
    June 2016
31. LUO Y, Zeng HQ, Shen Y, Zhang P, et al
    Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies.
    Leuk Res. 2016;48:6-10.
    PubMed     Text format     Abstract available
    
    
    
32. SAITO B, Hattori N, Yamamoto K, Arai N, et al
    Umbilical cord blood transplantation for adults using tacrolimus with two-day very-short-term methotrexate for graft-versus-host disease prophylaxis.
    Leuk Res. 2016;47:161-165.
    PubMed     Text format     Abstract available
    
    
    May 2016
33. TOMASIUK R, Gawronski K, Rzepecki P, Rabijewski M, et al
    The evaluation of NT-proCNP, C-reactive protein and serum amyloid A protein concentration in patients with multiple myeloma undergoing stem cell transplantation.
    Leuk Res. 2016;47:123-127.
    PubMed     Text format     Abstract available
    
    
    
34. CHATTERJEE R, Chattopadhyay S, Law S
    Alteration of classical and hematopoiesis specific p53 pathway in the bone marrow hematopoietic stem/progenitor compartment facilitates leukemia progression in experimental mice.
    Leuk Res. 2016;47:70-77.
    PubMed     Text format     Abstract available
    
    
    
35. WANG J, Hu J, Jin Z, Wan H, et al
    The sensitivity of chronic myeloid leukemia CD34 cells to Bcr-Abl tyrosine kinase inhibitors is modulated by ceramide levels.
    Leuk Res. 2016;47:32-40.
    PubMed     Text format     Abstract available
    
    
    
36. MEDINGER M, Heim D, Gerull S, Halter J, et al
    Increase of endothelial progenitor cells in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.
    Leuk Res. 2016;47:22-25.
    PubMed     Text format     Abstract available
    
    
    April 2016
37. KOUVIDI E, Stratigi A, Batsali A, Mavroudi I, et al
    Cytogenetic evaluation of mesenchymal stem/stromal cells from patients with myelodysplastic syndromes at different time-points during ex vivo expansion.
    Leuk Res. 2016;43:24-32.
    PubMed     Text format     Abstract available
    
    
    March 2016
38. CARRETT-DIAS M, Almeida LK, Pereira JL, Almeida DV, et al
    Cell differentiation and the multiple drug resistance phenotype in human erythroleukemic cells.
    Leuk Res. 2016;42:13-20.
    PubMed     Text format     Abstract available
    
    
    January 2016
39. TEOH HK, Chong PP, Abdullah M, Sekawi Z, et al
    Small interfering RNA silencing of interleukin-6 in mesenchymal stromal cells inhibits multiple myeloma cell growth.
    Leuk Res. 2016;40:44-53.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: